Abstract:Background: Antibiotic-associated gastrointestinal signs occurred in 100% of dogs administered enrofloxacin with metronidazole in a previous study, and signs partially were mitigated by synbiotics. The objective of this randomized, double-blinded, placebo-controlled trial was to compare the fecal microbiome and metabolome of dogs administered enrofloxacin and metronidazole, followed by either a placebo or a bacterial/yeast synbiotic combination. Methods: Twenty-two healthy research dogs were randomized to two treatment groups. There were three study periods: baseline, treatment, and washout. Dogs were administered enrofloxacin (10 mg/kg qd) and metronidazole (12.5 mg/kg BID), followed 1 h later by placebo or a commercially-available synbiotic combination (BID), per os for 21 days with reevaluation 56 days thereafter. Fecal samples were collected on days 5-7 (baseline), 26-28, and 82-84. The fecal microbiome was analyzed by qPCR and sequencing of 16S rRNA genes; time-of-flight mass spectrometry was used to determine metabolomic profiles. Split plot repeated measures mixed model ANOVA was used to compare results between treatment groups. P < 0.05 was considered significant, with Benjamini and Hochberg's False Discovery Rate used to adjust for multiple comparisons. Results: Alpha diversity metrics differed significantly over time in both treatment groups, with incomplete recovery by days 82-84. Beta diversity and the dysbiosis index differed significantly over time and between treatment groups, with incomplete recovery at days 82-84 for dogs in the placebo group. Significant group-by-time interactions were noted for 15 genera, including Adlercreutzia, Bifidobacterium, Slackia, Turicibacter, Clostridium (including C. hiranonis) [Ruminococcus], Erysipelotrichaceae_g_, [Eubacterium], and Succinivibrionaceae_g_. Concurrent group and time effects were present for six genera, including Collinsella, Ruminococcaceae_g_, and Prevotella. Metabolite profiles differed significantly by group-by-time, group, and time for 28, 20, and 192 metabolites, respectively. These included short-chain fatty acid, bile acid, tryptophan, sphingolipid, benzoic acid, and cinnaminic acid metabolites, as well as fucose and ethanolamine. Changes in many taxa and metabolites persisted through days 82-84. Conclusion: Antibiotic administration causes sustained dysbiosis and dysmetabolism in dogs. Significant group-by-time interactions were noted for a number of taxa and metabolites, potentially contributing to decreased antibiotic-induced gastrointestinal effects in dogs administered synbiotics.

[Metabolism of Roxithromycin in Dogs].

Lc-Esi-Ms Determination of Roxithromycin in Tissues of Beagle Dogs after Multiple Dosing of Roxithromycin Sustained Release Tablets

Pharmacokinetics of Metronidazole Colon-Targeted Capsules in Dogs

Inhibitory Mechanisms of Lekethromycin in Dog Liver Cytochrome P450 Enzymes Based on UPLC-MS/MS Cocktail Method

pH-dependent geometric isomerization of roxithromycin in simulated gastrointestinal fluids and in rats.

Pharmacokinetics and Metabolism of Cyadox and Its Main Metabolites in Beagle Dogs Following Oral, Intramuscular, and Intravenous Administration

Pharmacokinetics of clarithromycin citrate salt after oral administration to beagle dogs and food effects on its absorption.

Effects of Synbiotics on the Fecal Microbiome and Metabolomic Profiles of Healthy Research Dogs Administered Antibiotics: A Randomized, Controlled Trial

Effects of Roxithromycin on the Pharmacokinetics of Loratadine after Oral and Intravenous Administration of Loratadine in Rats

[Metabolic Kinetics of MN9202 in Beagle Dog Liver Microsomes].

Pharmacokinetics of methyl salicylate-2-O-β-D-lactoside, a novel salicylic acid analog isolated from Gaultheria yunnanensis, in dogs.

Bioavailability of Marbofloxacin in Dogs by Oral Administrate

Metabolism of mequindox in liver microsomes of rats, chicken and pigs.

Tertiary Oxidation of Deoxycholate is Predictive of CYP3A Activity in Dogs.

Exploring montelukast in dogs: A preliminary pharmacokinetic study following oral administration under fasted and fed conditions

Pharmacokinetics of Moxifloxacin Hydrochloride Tablet After oral administration in Beagle dogs

The effects of roxithromycin on the intestinal microbiota of BALB/c mice

Effects of metronidazole on the fecal microbiome and metabolome in healthy dogs

LC–ESI/MS Analysis of Levodopa and Methyldopa (IS) in Beagle Dog Pharmacokinetic Study after Oral Administration and Domperidone Given in Advance

In Vitro Metabolism of Cyadox in Rat, Chicken and Swine Using Ultra-Performance Liquid Chromatography Quadrupole Time-of-flight Mass Spectrometry

Study on Pharmacokinetics-Pharmacodynamics of Xinning Extended Action Tablet on Dogs